ACTIVE-6
Study / Research
A randomized trial of Ivermectin for COVID-19 treatment, funded by NIH and NIAID, with results expected in March 2023.
Mentioned in 1 video
A randomized trial of Ivermectin for COVID-19 treatment, funded by NIH and NIAID, with results expected in March 2023.
